We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0IDA market cap is 2.18B. The company's latest EPS is USD 0.2077 and P/E is 66.73.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.55M | 439.44M | 722.68M | 232.28M | 277.25M |
| Operating Income | -75.22M | 133.49M | 282.52M | -25.72M | -4.12M |
| Net Income | -75.24M | 72.14M | 292.87M | -6.39M | 27.31M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 353.27M | 1.04B | 985.85M | 997.1M | 986.26M |
| Total Liabilities | 294.58M | 816.87M | 404.84M | 375.02M | 389.46M |
| Total Equity | 58.69M | 222.37M | 581.01M | 622.07M | 596.8M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.25M | 335.53M | 62.72M | 100.56M | 66.51M |
| Investing | -26.53M | 14.23M | -316M | -153.93M | -18.04M |
| Financing | 109.5M | 55.78M | 19.53M | 1.39M | -102.02M |
| Market Cap | 2.18B |
| Price to Earnings Ratio | 66.73 |
| Price to Sales Ratio | 6.57 |
| Price to Cash Ratio | 19 |
| Price to Book Ratio | 3.05 |
| Dividend Yield | - |
| Shares Outstanding | 131.46M |
| Average Volume (1 week) | 1.1k |
| Average Volume (1 Month) | 977 |
| 52 Week Change | 0.00% |
| 52 Week High | 16.60 |
| 52 Week Low | 16.60 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Dynavax Technologies Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dynavax.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
